• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌进展中的肿瘤代谢重编程

Tumor metabolic reprogramming in lung cancer progression.

作者信息

Li Xin, Liu Minghui, Liu Hongyu, Chen Jun

机构信息

Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.

Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China.

出版信息

Oncol Lett. 2022 Jun 28;24(2):287. doi: 10.3892/ol.2022.13407. eCollection 2022 Aug.

DOI:10.3892/ol.2022.13407
PMID:35814833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9260716/
Abstract

Metabolic reprogramming is an important characteristic of tumor cells. Tumor cells reprogram their metabolic pathways to meet the material, energy and redox force needs for rapid proliferation. Metabolic reprogramming changes the level or type of specific metabolites inside and outside cells, and promotes tumor growth by affecting gene expression, cell state and the tumor microenvironment. Glucose metabolism, glutamine metabolism and lipid metabolism are significant metabolic pathways in tumors. Targeting metabolic reprogramming can significantly inhibit tumor growth and induce apoptosis. Metabolic reprogramming also plays an important role in maintaining the growth advantage of tumor cells and enhancing the chemotherapy tolerance of lung cancer. This review summarizes abnormal changes in the metabolism of glucose, fat and amino acids in lung cancer, and the underlying molecular mechanism, with the aim of providing novel ideas for the prevention, early diagnosis and treatment of lung cancer.

摘要

代谢重编程是肿瘤细胞的一个重要特征。肿瘤细胞重新编程其代谢途径,以满足快速增殖所需的物质、能量和氧化还原力需求。代谢重编程改变细胞内外特定代谢物的水平或类型,并通过影响基因表达、细胞状态和肿瘤微环境来促进肿瘤生长。葡萄糖代谢、谷氨酰胺代谢和脂质代谢是肿瘤中重要的代谢途径。靶向代谢重编程可显著抑制肿瘤生长并诱导细胞凋亡。代谢重编程在维持肿瘤细胞的生长优势和增强肺癌的化疗耐受性方面也发挥着重要作用。本综述总结了肺癌中葡萄糖、脂肪和氨基酸代谢的异常变化及其潜在分子机制,旨在为肺癌的预防、早期诊断和治疗提供新思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c62/9260716/021be321b26d/ol-24-02-13407-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c62/9260716/021be321b26d/ol-24-02-13407-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c62/9260716/021be321b26d/ol-24-02-13407-g00.jpg

相似文献

1
Tumor metabolic reprogramming in lung cancer progression.肺癌进展中的肿瘤代谢重编程
Oncol Lett. 2022 Jun 28;24(2):287. doi: 10.3892/ol.2022.13407. eCollection 2022 Aug.
2
Glutamine metabolism in breast cancer and possible therapeutic targets.乳腺癌中的谷氨酰胺代谢及潜在治疗靶点。
Biochem Pharmacol. 2023 Apr;210:115464. doi: 10.1016/j.bcp.2023.115464. Epub 2023 Feb 26.
3
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.肿瘤免疫微环境中的代谢重编程:对免疫细胞功能的影响及其治疗意义。
Cancer Lett. 2024 Aug 10;597:217076. doi: 10.1016/j.canlet.2024.217076. Epub 2024 Jun 19.
4
Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells.肿瘤热疗通过影响肿瘤细胞代谢重编程的研究进展。
Int J Hyperthermia. 2023;40(1):2270654. doi: 10.1080/02656736.2023.2270654. Epub 2023 Oct 23.
5
The role of metabolic reprogramming in pancreatic cancer chemoresistance.代谢重编程在胰腺癌化疗耐药中的作用。
Front Pharmacol. 2023 Jan 9;13:1108776. doi: 10.3389/fphar.2022.1108776. eCollection 2022.
6
Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification.MYCN 扩增的胚胎性肿瘤中的脂质代谢重编程
Cancers (Basel). 2023 Apr 4;15(7):2144. doi: 10.3390/cancers15072144.
7
Amino acid metabolic reprogramming in tumor metastatic colonization.肿瘤转移定植中的氨基酸代谢重编程
Front Oncol. 2023 Mar 14;13:1123192. doi: 10.3389/fonc.2023.1123192. eCollection 2023.
8
Intracellular metabolic reprogramming mediated by micro-RNAs in differentiating and proliferating cells under non-diseased conditions.在非疾病状态下,微小RNA介导的分化和增殖细胞中的细胞内代谢重编程。
Mol Biol Rep. 2021 Dec;48(12):8123-8140. doi: 10.1007/s11033-021-06769-0. Epub 2021 Oct 13.
9
Cancer metabolism and intervention therapy.癌症代谢与干预治疗。
Mol Biomed. 2021 Feb 20;2(1):5. doi: 10.1186/s43556-020-00012-1.
10
Does oncolytic viruses-mediated metabolic reprogramming benefit or harm the immune microenvironment?溶瘤病毒介导的代谢重编程对免疫微环境是有益还是有害?
FASEB J. 2024 Feb 15;38(3):e23450. doi: 10.1096/fj.202301947RR.

引用本文的文献

1
Light-emitting diode irradiation targets aerobic glycolysis in cancer-associated fibroblasts to inhibit metabolic coupling with colon cancer cells.发光二极管照射靶向癌症相关成纤维细胞中的有氧糖酵解,以抑制与结肠癌细胞的代谢偶联。
Ann Gastroenterol Surg. 2025 Feb 24;9(4):761-768. doi: 10.1002/ags3.70004. eCollection 2025 Jul.
2
Acetylation-induced degradation of ECHS1 enhances BCAA accumulation and proliferation in KRAS-mutant colorectal cancer.乙酰化诱导的ECHS1降解增强了KRAS突变型结直肠癌中的支链氨基酸积累和增殖。
J Exp Clin Cancer Res. 2025 May 28;44(1):164. doi: 10.1186/s13046-025-03399-3.
3
A nicotinamide metabolism-related gene signature for predicting immunotherapy response and prognosis in lung adenocarcinoma patients.

本文引用的文献

1
Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression.Fascin 通过增强糖酵解和 PFKFB3 表达促进肺癌生长和转移。
Cancer Lett. 2021 Oct 10;518:230-242. doi: 10.1016/j.canlet.2021.07.025. Epub 2021 Jul 22.
2
Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model.阿司匹林触发的消退素D1在KRAS突变驱动的肺腺癌模型中降低增殖和中性粒细胞与淋巴细胞比值
Cancers (Basel). 2021 Jun 28;13(13):3224. doi: 10.3390/cancers13133224.
3
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors.
一种用于预测肺腺癌患者免疫治疗反应和预后的烟酰胺代谢相关基因特征。
PeerJ. 2025 Feb 27;13:e18991. doi: 10.7717/peerj.18991. eCollection 2025.
4
The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells.ESM1在肺腺癌细胞脂质代谢重编程和血管生成中的作用。
Heliyon. 2024 Aug 24;10(17):e36897. doi: 10.1016/j.heliyon.2024.e36897. eCollection 2024 Sep 15.
5
Phosphoenolpyruvate carboxykinase 2-mediated metabolism promotes lung tumorigenesis by inhibiting mitochondrial-associated apoptotic cell death.磷酸烯醇式丙酮酸羧激酶2介导的代谢通过抑制线粒体相关的凋亡细胞死亡促进肺癌发生。
Front Pharmacol. 2024 Aug 9;15:1434988. doi: 10.3389/fphar.2024.1434988. eCollection 2024.
6
Reprogramming hematopoietic stem cell metabolism in lung cancer: glycolysis, oxidative phosphorylation, and the role of 2-DG.重塑肺癌造血干细胞代谢:糖酵解、氧化磷酸化和 2-DG 的作用。
Biol Direct. 2024 Aug 24;19(1):73. doi: 10.1186/s13062-024-00514-w.
7
Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways.解析肺癌、耐药性和代谢途径的三联征
Diseases. 2024 May 6;12(5):93. doi: 10.3390/diseases12050093.
8
Enigmatic exosomal connection in lung cancer drug resistance.肺癌耐药中神秘的外泌体联系
Mol Ther Nucleic Acids. 2024 Mar 22;35(2):102177. doi: 10.1016/j.omtn.2024.102177. eCollection 2024 Jun 11.
9
Unveiling the STAT3-ACC1 axis: a key driver of lipid metabolism and tumor progression in non-small cell lung cancer.揭示STAT3-ACC1轴:非小细胞肺癌脂质代谢和肿瘤进展的关键驱动因素。
J Cancer. 2024 Mar 4;15(8):2340-2353. doi: 10.7150/jca.93890. eCollection 2024.
10
FFAR4 activation inhibits lung adenocarcinoma via blocking respiratory chain complex assembly associated mitochondrial metabolism.FFAR4 激活通过阻断与线粒体代谢相关的呼吸链复合物组装抑制肺腺癌。
Cell Mol Biol Lett. 2024 Jan 19;29(1):17. doi: 10.1186/s11658-024-00535-3.
一流的脂肪酸合酶抑制剂TVB-2640单药及与紫杉烷联合用于晚期肿瘤的人体首次安全性、药代动力学和药效学研究。
EClinicalMedicine. 2021 Mar 30;34:100797. doi: 10.1016/j.eclinm.2021.100797. eCollection 2021 Apr.
4
The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.己糖胺生物合成途径与癌症:当前的认识和未来的治疗策略。
Cancer Lett. 2021 Apr 10;503:11-18. doi: 10.1016/j.canlet.2021.01.010. Epub 2021 Jan 20.
5
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer.己糖胺生物合成途径是 KRAS/LKB1 突变型肺癌的一个可靶向的缺陷。
Nat Metab. 2020 Dec;2(12):1401-1412. doi: 10.1038/s42255-020-00316-0. Epub 2020 Nov 30.
6
Metabolic communication during exercise.运动期间的代谢通讯。
Nat Metab. 2020 Sep;2(9):805-816. doi: 10.1038/s42255-020-0258-x. Epub 2020 Aug 3.
7
PFKP is highly expressed in lung cancer and regulates glucose metabolism.PFKP 在肺癌中高表达,并调节葡萄糖代谢。
Cell Oncol (Dordr). 2020 Aug;43(4):617-629. doi: 10.1007/s13402-020-00508-6. Epub 2020 Mar 26.
8
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.靶向肝脏谷氨酰胺酶1通过恢复极低密度脂蛋白甘油三酯组装来改善非酒精性脂肪性肝炎。
Cell Metab. 2020 Mar 3;31(3):605-622.e10. doi: 10.1016/j.cmet.2020.01.013. Epub 2020 Feb 21.
9
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.磷脂和胆固醇:癌症多药耐药的诱导剂和治疗靶点。
Drug Resist Updat. 2020 Mar;49:100670. doi: 10.1016/j.drup.2019.100670. Epub 2019 Nov 29.
10
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer.为癌症机器加油:脂质代谢在癌症中的作用。
Cell Metab. 2020 Jan 7;31(1):62-76. doi: 10.1016/j.cmet.2019.11.010. Epub 2019 Dec 5.